Matches in Wikidata for { <http://www.wikidata.org/entity/Q100729630> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q100729630 description "2020 ވަނަ އަހަރުގެ އޮކްޓޯބަރުމަހުގެ 19ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ލިޔުމެއް" @default.
- Q100729630 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q100729630 description "scientific article published on 19 October 2020" @default.
- Q100729630 description "wetenschappelijk artikel" @default.
- Q100729630 description "наукова стаття, опублікована 19 жовтня 2020" @default.
- Q100729630 description "գիտական հոդված հրատարակված 2020 թվականի հոկտեմբերի 19-ին" @default.
- Q100729630 name "Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study" @default.
- Q100729630 name "Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study" @default.
- Q100729630 name "Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study" @default.
- Q100729630 type Item @default.
- Q100729630 label "Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study" @default.
- Q100729630 label "Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study" @default.
- Q100729630 label "Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study" @default.
- Q100729630 prefLabel "Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study" @default.
- Q100729630 prefLabel "Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study" @default.
- Q100729630 prefLabel "Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study" @default.
- Q100729630 P1433 Q100729630-60375F48-59E8-421E-AEC0-F796C82D9CB8 @default.
- Q100729630 P1476 Q100729630-F0885ABC-B160-4A87-BA2B-C188FC0B00B4 @default.
- Q100729630 P2093 Q100729630-08D6C5EF-8018-4EE1-ABC8-62A64D37E13D @default.
- Q100729630 P2093 Q100729630-915EB7B1-08DD-4B26-8109-A036C7D0B50C @default.
- Q100729630 P2093 Q100729630-B0EB0980-A239-4D50-B791-3172874F7DC7 @default.
- Q100729630 P2093 Q100729630-B60DDA33-03B0-4462-AE32-DB0C2E929D7D @default.
- Q100729630 P2093 Q100729630-E9030C95-7040-4F75-A5D8-472913A95FC8 @default.
- Q100729630 P2093 Q100729630-EF6A1222-6543-4E61-90D3-504554A607C0 @default.
- Q100729630 P2093 Q100729630-F5E95891-B7B9-48A6-874D-02BE1B8E0459 @default.
- Q100729630 P31 Q100729630-B81B9942-4396-4A74-85C2-3109FDEF95BF @default.
- Q100729630 P356 Q100729630-BD6D61B5-33CE-4077-8DBD-88540D3D69D1 @default.
- Q100729630 P50 Q100729630-A829F7FF-4C61-4702-895D-07E66C39659C @default.
- Q100729630 P50 Q100729630-CC2D532B-1A7C-40FF-BDC0-23F9162CF8A5 @default.
- Q100729630 P50 Q100729630-E604151E-2AD9-4F74-8BE9-93E03E7932CC @default.
- Q100729630 P577 Q100729630-65A32C5E-A526-480E-8314-2ED7CDC94A44 @default.
- Q100729630 P698 Q100729630-AC2FA665-D5BE-4632-B4A6-DBBD18C6FAB1 @default.
- Q100729630 P921 Q100729630-55196AE8-0767-47D1-B290-E65DABB350DC @default.
- Q100729630 P932 Q100729630-909A5ACA-950E-4F65-85EA-E4C4571D9001 @default.
- Q100729630 P356 1759-7714.13687 @default.
- Q100729630 P698 33073527 @default.
- Q100729630 P1433 Q26842004 @default.
- Q100729630 P1476 "Efficacy and safety of bevacizumab in advanced lung adenocarcinoma patients with stable disease after two cycles of first-line chemotherapy: A multicenter prospective cohort study" @default.
- Q100729630 P2093 "Fan Yang" @default.
- Q100729630 P2093 "Jun Chen" @default.
- Q100729630 P2093 "Li Zhang" @default.
- Q100729630 P2093 "Shengyu Zhou" @default.
- Q100729630 P2093 "Xingsheng Hu" @default.
- Q100729630 P2093 "Yi Hu" @default.
- Q100729630 P2093 "Zhe Liu" @default.
- Q100729630 P31 Q13442814 @default.
- Q100729630 P356 "10.1111/1759-7714.13687" @default.
- Q100729630 P50 Q100729629 @default.
- Q100729630 P50 Q89063526 @default.
- Q100729630 P50 Q90255537 @default.
- Q100729630 P577 "2020-10-19T00:00:00Z" @default.
- Q100729630 P698 "33073527" @default.
- Q100729630 P921 Q413299 @default.
- Q100729630 P932 "7705615" @default.